S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in

Neurotech International Limited (NTI.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism, a portable electroencephalographic medical device that uses neuro feedback to relax the minds of children with autism spectrum disorder. The company focuses on developing neuro-stimulation and neuro-diagnostic solutions that enable medical practitioners to monitor and play an active role in home-based therapies. It also engages in executing of medical research projects; and developing of technological devices and other solutions for the screening and treatment of neurological disorders. The company was incorporated in 2016 and is based in Nedlands, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Phone61 8 9389 3130



Sales & Book Value

Annual Sales$80,341.00
Book ValueA$0.00 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive NTI News and Ratings via Email

Sign-up to receive the latest news and ratings for NTI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Neurotech International Limited (NTI.AX) (ASX:NTI) Frequently Asked Questions

What stocks does MarketBeat like better than Neurotech International Limited (NTI.AX)?

Wall Street analysts have given Neurotech International Limited (NTI.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Neurotech International Limited (NTI.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Neurotech International Limited (NTI.AX)'s key competitors?

Who are Neurotech International Limited (NTI.AX)'s key executives?

Neurotech International Limited (NTI.AX)'s management team includes the following people:
  • Mr. Peter James Lawrence Griffiths B.Sc., Chief Exec. Officer of AAT Research Ltd (Age 56, Pay $282.17k)
  • Dr. Emanuela Russo, Chief Scientific Officer & Member of Scientific Advisory Board
  • Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACIS, Company Sec.

What is Neurotech International Limited (NTI.AX)'s stock symbol?

Neurotech International Limited (NTI.AX) trades on the ASX under the ticker symbol "NTI."

How big of a company is Neurotech International Limited (NTI.AX)?

Neurotech International Limited (NTI.AX) has a market capitalization of $0.00 and generates $80,341.00 in revenue each year.

What is Neurotech International Limited (NTI.AX)'s official website?

The official website for Neurotech International Limited (NTI.AX) is www.neurotechinternational.com.

How can I contact Neurotech International Limited (NTI.AX)?

The company can be reached via phone at 61 8 9389 3130.

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.